Filter Specialty
Submit To The Journals

ECCO 2017 – A New PARP Inhibitor to Clinical Practice

Dr Mansoor Raza Mirza introduces the satellite symposium session titled "A New PARP Inhibitor to Clinical Practice".

Dr Nelleke Ottevanger presents on the topic "Current treatment standards for patients with ovarian cancer' at ECCO 2017.

Isabelle Ray-Coquard discusses the rationale for PARP inhbitors in the treatment of ovarian cancer.

In the fourth presentation in this symposium, Domenica Lorusso discusses the role of niraparib in ovarian cancer.

Jalid Sehouli explores the benefits of PARP inhibitors from a patient's perspective in this final section of the symposium.

  • Touch Medical Media Limited, trading as Touch Medical Media, is a private limited company registered in England and Wales at The White House, Mill Road, Goring, Reading, England, RG8 9DD with registered number 08197142. © 2019 All rights reserved.

    touchONCOLOGY is for informational purposes and intended for healthcare professionals only. Its content should not be considered medical advice, diagnosis or treatment recommendations.